Skip to main content
LLY
NYSE Life Sciences

Lilly Endowment Files to Sell $344M in LLY Stock Amid Ongoing Dispositions

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1,201.225
Mkt Cap
$1.131T
52W Low
$623.78
52W High
$1,208.18
52W Position info
93% above low
Off High info
at 52W high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

LLY sits 93% above its 52-week low of $623.78.

Summary

Lilly Endowment, a major shareholder, plans to sell $344 million in Eli Lilly stock, continuing a pattern of large dispositions totaling nearly $1.3 billion in the last three months.


Key Events · Ownership and Investor Activity · LLY

  • Proposed Stock Sale

    Lilly Endowment, Inc. intends to sell 305,000 shares of Eli Lilly common stock, valued at approximately $343.9 million.

  • Ongoing Share Dispositions

    This filing is part of a larger pattern, with the endowment having sold 1,215,000 shares totaling nearly $1.3 billion over the past three months.

  • Shareholder Activity Near 52-Week Highs

    The sales by the major shareholder occur while Eli Lilly's stock is trading near its 52-week high, potentially indicating profit-taking or portfolio rebalancing.


Analysis · LLY · Life Sciences

Lilly Endowment, Inc., a significant shareholder, has filed a Form 144 indicating its intent to sell approximately $344 million worth of Eli Lilly common stock. This proposed sale follows nearly $1.3 billion in sales by the endowment over the past three months, part of a consistent pattern of dispositions. While substantial in absolute dollar terms, these sales represent a small fraction of Eli Lilly's total market capitalization. The sales occur as the stock trades near its 52-week high, suggesting potential profit-taking or portfolio rebalancing by the endowment.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LLY was trading at $1,201.23 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $623.78 to $1,208.18. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 18, 2026, 3:04 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,381.18
Real-time Price: $1,348.06 info
Change: -$33.12 (-2%) info
Market Cap: $1.267T info
LLY
Nov 17, 2026, 11:18 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,416.23
Real-time Price: $1,348.06 info
Change: -$68.17 (-5%) info
Market Cap: $1.267T info
LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,348.06 info
Change: -$107.30 (-7%) info
Market Cap: $1.267T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,348.06 info
Change: -$104.64 (-7%) info
Market Cap: $1.267T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,348.06 info
Change: -$99.79 (-7%) info
Market Cap: $1.267T info